Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma

Frontiers in Medicine

Medicine

Hanwen Lu¹  Huiyin Yang¹  Zhanxiang Wang²  Liwei Zhou³  Yuanyuan Xie³  Bingchang Zhang³ 

[1] Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China;Department of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, China;Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China;Department of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, China;Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China;Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China;Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China;

关键词: Cuproptosis;    glioma;    prognostic biomarker;    immune infiltration;    lipoylation;   

DOI  :  10.3389/fmed.2023.1244638

 received in 2023-06-22, accepted in 2023-06-23,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Lu, Zhou, Zhang, Xie, Yang and Wang.